leisure time -WSS

leisure time

author：focus 2025-09-05 15:43:09 - browse：28

JOSEPH PREZIOSO/AFP via Getty Images

LONDON — The U.K.’s cost-effectiveness watchdog said Thursday it is not yet recommending Vertex’s CRISPR-based therapy for sickle cell disease, saying in draft guidance it has questions about the medicine’s lasting benefits for patients.

U.K. regulators approved the therapy, known as Casgevy or exa-cel, last year, granting it the world’s first authorization for any CRISPR-based medicine. But observers have been watching to see how the U.K.’s National Institute for Health and Care Excellence, as well as similar agencies in European countries, would view the pricey, one-time therapy. NICE needs to recommend the therapy for it to be offered in the National Health Service.

In the U.S., Casgevy has a list price of $2.2 million. It was developed by Vertex in partnership with CRISPR Therapeutics.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： What causes osteoarthritis? Researchers study link to brain protein

WSS

Update the Apgar Score to remove skin color

Device maker Teleflex to acquire urology company for $600M

HPV vaccine, cervical cancer study delivers historic results

Roche’s Alnylam deal shows drug firms interested in heart drugs

Bronny James, LeBron's son, suffers cardiac arrest during basketball practice at USC

Inaction leaves children at risk from dangerous chemotherapy drug

focus

leisure time

leisure time

The high cost of giving birth even with insurance

Readout Newsletter: Parkinson's study, Gilead, CG Oncology

In Memoriam: Notable people who died in 2023

What causes rare myocarditis in young men after Covid vaccines?

Apple is now the first public company to be valued at $3 trillion

Dog Aging Project founders on what lies ahead after losing funding

Apple is now the first public company to be valued at $3 trillion

Readout Newsletter: Parkinson's study, Gilead, CG Oncology

Hollywood unions extend contract negotiations for actors

A pediatrician calls for Congress to pass the child tax credit deal

hotspot

New Alzheimer's drugs heat up race for early detection blood tests

Future doctors need a strong humanities education

In the gardens at Boston Children's Hospital, families find sanctuary

What it's like to live with paralysis for one psychologist

What causes rare myocarditis in young men after Covid vaccines?

Immunocompromised patients offer clues on chronic Covid

focus

Wikipedia

entertainment

explore